Solvay NovecareArticles & NewsNewsDMC Biotechnologies Receives $34 Million Series B FundingDMC Biotechnologies creates scalable biocatalysts through microbial fermentation, resulting in bio-based chemicals for animal feed, human nutrition, sustainable cleaning and pharmaceutical applications.
